☆ 4.4 Article

F-box and leucine-rich repeat 6 promotes gastric cancer progression via the promotion of epithelial-mesenchymal transition

WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Add to Collection

Article Cell Biology

FBXO2 targets glycosylated SUN2 for ubiquitination and degradation to promote ovarian cancer development

Jing Ji et al.

Summary: The study reveals that FBXO2 acts as an E3 ubiquitin ligase and promotes the degradation of SUN2 protein, which is associated with worse prognosis in ovarian cancer. The transcription factor SOX6 enhances the expression of FBXO2 by recognizing a response element on its promoter. Abnormally high expression of FBXO2 leads to degradation of SUN2 protein, promoting cell proliferation and ultimately contributing to the progression of ovarian cancer.

CELL DEATH & DISEASE (2022)

Add to Collection

Article Oncology

FBXL6 depletion restrains clear cell renal cell carcinoma progression

Yongchun Yu et al.

Summary: In this study, a survival model based on the F-box gene signature was established to evaluate the prognosis of patients with ccRCC. FBXL6 was identified as a diagnostic and prognostic marker in ccRCC. In vitro and in vivo experiments demonstrated that the depletion of FBXL6 inhibited cell proliferation and induced apoptosis in ccRCC cells.

TRANSLATIONAL ONCOLOGY (2022)

Add to Collection

Article Pathology

FBXO39 predicts poor prognosis and correlates with tumor progression in cervical squamous cell carcinoma

Yanru Yang et al.

Summary: The study found that FBXO39 is highly expressed in cervical squamous cell carcinoma and is closely related to patient prognosis. Further experiments confirmed that overexpression of FBXO39 promotes the proliferation, migration, and invasion of cancer cells. Experimental results on C-33A cells showed that downregulation of FBXO39 can inhibit tumor growth. These findings suggest that FBXO39 may serve as a therapeutic target for cervical squamous cell carcinoma (CESC).

PATHOLOGY RESEARCH AND PRACTICE (2022)

Add to Collection

Review Immunology

Therapeutic strategies for gastric cancer targeting immune cells: Future directions

Yan Zhao et al.

Summary: Gastric cancer is a highly prevalent and lethal malignancy, and immunotherapy has shown survival benefits for GC patients. Targeted immune cells have emerged as a promising therapeutic strategy in the field of oncology. This review discusses the role and significance of immune cells in the tumor microenvironment of GC and summarizes the current landscape of immunotherapy, including immune checkpoint inhibitors and adoptive cell therapy. While more clinical data is needed, targeting immune cells provides a new direction for GC immunotherapy.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Review Oncology

A Bayesian network meta-analysis on systemic therapy for previously treated gastric cancer

Jung Han Kim et al.

Summary: A systematic literature review identified 20 phase III randomized controlled trials on salvage treatment of advanced gastric cancer, with olaparib plus paclitaxel, paclitaxel plus ramucirumab, and pembrolizumab showing potential as the most effective regimens. Moreover, nivolumab, chemotherapy, and apatinib demonstrated significant overall survival benefit compared to best supportive care for third-line treatment. In conclusion, pembrolizumab may be preferable for PD-L1-expressing AGC in the second-line setting, while paclitaxel-based combinations are recommended for PD-L1-negative AGC, and nivolumab may be the preferred third-line treatment.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

FBXL6 degrades phosphorylated p53 to promote tumor growth

Yajun Li et al.

Summary: This study identified the amplified and over-expressed FBXL6 in colorectal cancer patients, which is highly correlated with poor prognosis, and revealed its mechanism in suppressing p53 signaling by targeting phospho-p53 for degradation. The feed-forward loop of FBXL6-p53, where p53 transcriptionally suppresses FBXL6 expression, might serve as a potential therapeutic target for CRC treatments.

CELL DEATH AND DIFFERENTIATION (2021)

Add to Collection

Article Oncology

HOXA10 mediates epithelial-mesenchymal transition to promote gastric cancer metastasis partly via modulation of TGFB2/Smad/METTL3 signaling axis

Chenlong Song et al.

Summary: Our study demonstrated that HOXA10 is upregulated in gastric cancer, especially in patients with lymph node metastasis. Functionally, HOXA10 promotes migration and invasion of gastric cancer cells, as well as accelerates lung metastasis in vivo. The EMT process mediated by the HOXA10/TGFB2/Smad/METTL3 signaling axis plays a crucial role in gastric cancer progression and metastasis.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Regulation of valproic acid induced EMT by AKT/GSK3β/β-catenin signaling pathway in triple negative breast cancer

Zeynep Ozman et al.

Summary: The study demonstrated that valproic acid (VPA) induces epithelial-to-mesenchymal transition (EMT) and cell migration in triple negative breast cancer cells by regulating the expression levels of Snail, E-cadherin, AKT, and GSK3 beta.

MOLECULAR BIOLOGY REPORTS (2021)

Add to Collection

Article Cell Biology

Tenascin-c knockdown suppresses vasculogenic mimicry of gastric cancer by inhibiting ERK- triggered EMT

Xing Kang et al.

Summary: The study found that Tenascin-c (TNC) is upregulated in gastric cancer tissue and is associated with vasculogenic mimicry (VM) formation and poor prognosis. Inhibition of TNC can significantly suppress VM formation and cell proliferation in gastric cancer. Targeting TNC and ERK may be a potential therapeutic approach to inhibit gastric cancer growth and metastasis.

CELL DEATH & DISEASE (2021)

Add to Collection

Article Oncology

mRNA Expression Analysis of E-Cadherin, VEGF, and MMPs in Gastric Cancer: a Pilot Study

Puneet Kumar et al.

Summary: This study investigated the mRNA expression of VEGF, E-cadherin, and MMPs in gastric cancer tissues in the Indian population. Results showed differences in the expression levels of these genes compared to control tissues. Analysis was done on the diagnostic utility and association of these genes with clinicopathological characteristics and prognosis.

INDIAN JOURNAL OF SURGICAL ONCOLOGY (2021)

Add to Collection

Article Cell Biology

SNHG7 accelerates cell migration and invasion through regulating miR-34a-Snail-EMT axis in gastric cancer

Yangmei Zhang et al.

CELL CYCLE (2020)

Add to Collection

Article Biochemistry & Molecular Biology

The F-box protein FBXL16 up-regulates the stability of C-MYC oncoprotein by antagonizing the activity of the F-box protein FBW7

Marion Morel et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2020)

Add to Collection

Article Cell Biology

FBXL6 governs c-MYC to promote hepatocellular carcinoma through ubiquitination and stabilization of HSP90AA1

Weidong Shi et al.

CELL COMMUNICATION AND SIGNALING (2020)

Add to Collection

Article Biochemistry & Molecular Biology

MiR-122-5p suppresses the proliferation, migration, and invasion of gastric cancer cells by targeting LYN

Lei Meng et al.

ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2020)

Add to Collection

Article Oncology

Tumor-associated neutrophils induce EMT by IL-17a to promote migration and invasion in gastric cancer cells

Sen Li et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)

Add to Collection

Review Cell Biology

EMT Transition States during Tumor Progression and Metastasis

Ievgenia Pastushenko et al.

TRENDS IN CELL BIOLOGY (2019)

Add to Collection

Article Multidisciplinary Sciences

A Multidimensional Characterization of E3 Ubiquitin Ligase and Substrate Interaction Network

Di Chen et al.

ISCIENCE (2019)

Add to Collection

Article Oncology

LOX inhibition downregulates MMP-2 and MMP-9 in gastric cancer tissues and cells

Lei Zhao et al.

JOURNAL OF CANCER (2019)

Add to Collection

Article Biochemistry & Molecular Biology

FBXO22 Suppresses Metastasis in Human Renal Cell Carcinoma via Inhibiting MMP-9-Mediated Migration and Invasion and VEGF-Mediated Angiogenesis

Feng Guo et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)

Add to Collection

Article Oncology

ITGBL1 Predicts a Poor Prognosis and Correlates EMT Phenotype in Gastric Cancer

Rongkun Li et al.

JOURNAL OF CANCER (2017)

Add to Collection

Review Oncology

Measuring Intragastric Tumor Markers in Gastric Cancer Patients: a Systematic Literature Review on Significance and Reliability

Edoardo Virgilio et al.

ANTICANCER RESEARCH (2017)

Add to Collection

Review Public, Environmental & Occupational Health

Esophageal cancer in high-risk areas of China: research progress and challenges

Yingsong Lin et al.

ANNALS OF EPIDEMIOLOGY (2017)

Add to Collection

Review Oncology

Involvement of F-BOX proteins in progression and development of human malignancies

Shahab Uddin et al.

SEMINARS IN CANCER BIOLOGY (2016)

Add to Collection

Article Oncology

F-box protein interactions with the hallmark pathways in cancer

Suzanne J. Randle et al.

SEMINARS IN CANCER BIOLOGY (2016)

Add to Collection

Review Biochemistry & Molecular Biology

EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness

Ester Sanchez-Tillo et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2012)

Add to Collection

Article Oncology

Epithelial-Mesenchymal Transition (EMT) in Tumor-Initiating Cells and Its Clinical Implications in Breast Cancer

Chad J. Creighton et al.

JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2010)

Add to Collection

Article Biochemistry & Molecular Biology

Downregulation of vertebrate Tel (ETV6) and Drosophila Yan is facilitated by an evolutionarily conserved mechanism of F-box-mediated ubiquitination

M. Guy Roukens et al.

MOLECULAR AND CELLULAR BIOLOGY (2008)

Add to Collection

© Peeref 2019-2024. All rights reserved.